Teamwork Financial Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,506
Closed -$307K 308
2021
Q4
$307K Sell
3,506
-66
-2% -$5.48K 0.06% 235
2021
Q3
$292K Hold
3,572
0.06% 219
2021
Q2
$326K Buy
3,572
+166
+5% +$14.8K 0.07% 187
2021
Q1
$291K Buy
3,406
+81
+2% +$7.27K 0.07% 189
2020
Q4
$314K Hold
3,325
0.07% 160
2020
Q3
$289K Hold
3,325
0.09% 144
2020
Q2
$290K Hold
3,325
0.1% 147
2020
Q1
$274K Buy
+3,325
New +$297K 0.17% 93

Other funds holding NVS

Teamwork Financial Advisors's NVS Position: Q1 2022 in Review

Teamwork Financial Advisors sold out of Novartis (NVS) in Q1 2022, closing a stake of 3,506 shares — an estimated $307K sold.

Teamwork Financial Advisors first reported a position in NVS in Q1 2020 and held it in 8 quarters. The position peaked at $326K in Q2 2021. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

  • Teamwork Financial Advisors reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
  • Teamwork Financial Advisors sold 3,506 Novartis shares in Q1 2022, an estimated $307K.
  • Teamwork Financial Advisors first reported a position in Novartis in Q1 2020 and held it in 8 quarters.
  • Teamwork Financial Advisors's Novartis position peaked at $326K in Q2 2021.
  • 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on Teamwork Financial Advisors's 13F filing for Q1 2022, filed 18 Apr 2022.